New insider activity at Cardinal Health ( (CAH) ) has taken place on February 10, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Patricia Hemingway Hall has recently sold 4,000 shares of Cardinal Health stock in a transaction valued at $918,880, signaling a notable insider move at the healthcare services company.
Recent Updates on CAH stock
Cardinal Health shares reacted to a strong Q2 report, as revenue and EPS topped expectations and management raised its 2026 earnings outlook. The guidance boost was driven by double-digit profit growth across all five segments, especially pharma and specialty, margin expansion from tight cost control, and robust cash generation that improved leverage and supports ongoing growth investments despite headwinds from tariffs, higher interest costs, and some temporary volume timing benefits that are expected to normalize.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Outperform.
The score is driven primarily by strong technical momentum and a very positive earnings update with raised FY26 EPS guidance and broad-based profit growth. Financial performance is supported by large and growing free cash flow, but weighed down by balance-sheet risk (negative equity and meaningful debt). Valuation is a secondary headwind due to the higher P/E and low dividend yield.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
YTD Price Performance: 10.13%
Average Trading Volume: 2,033,476
Technical Sentiment Signal: Buy
Current Market Cap: $53.26B